Dr Rachel Jones - Publications
-
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis
View publication (opens in a new tab)15 Jul 2010
-
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
View publication (opens in a new tab)04 Mar 2015
-
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
View publication (opens in a new tab)24 Jun 2022
-
Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis
View publication (opens in a new tab)01 Aug 2019
-
Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
View publication (opens in a new tab)01 Mar 2021
-
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines
View publication (opens in a new tab)01 Apr 2020
-
Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease
View publication (opens in a new tab)01 Dec 2014
-
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
View publication (opens in a new tab)05 Jan 2019
-
Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial
View publication (opens in a new tab)01 Jun 2018
-
Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
View publication (opens in a new tab)01 Apr 2020
-
SARS-COV-2 vaccine responses in renal patient populations
View publication (opens in a new tab)01 May 2022